SecBot SecBot
SECBOTREPLAY Home › Report › AXSM

AXSM · Director Roger Jeffs filed a Form 144 to sell 286 shares of Axsome…

Axsome Therapeutics, Inc. · 144 filed Jun 11, 2026 at 17:09 ET

At the news

NEUTRALIMPACT 1/10

144 filed Jun 11, 2026 at 17:09 ET

Director Roger Jeffs filed a Form 144 to sell 286 shares of Axsome Therapeutics common stock, valued at approximately $70,407. The shares originated from a restricted stock lapse on June 6, 2026, and the sale appears to be a routine tax-withholding transaction. The dollar amount is negligible relative to the company's $12.7B market cap, making this filing inconsequential for traders.

  • Director Roger Jeffs filed Form 144 to sell 286 shares of common stock.
  • Estimated sale value of $70,407 based on June 10, 2026 trade.
  • Shares originated from a restricted stock lapse (equity compensation) on June 6, 2026.
  • Sale constitutes a trivial fraction of the company's $12.7B market capitalization.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access